Comparison of Osteoprotegerin to Traditional Atherosclerotic Risk Factors and High-Sensitivity C-Reactive Protein for Diagnosis of Atherosclerosis

被引:86
作者
Mogelvang, Rasmus [1 ,2 ]
Pedersen, Sune H. [3 ]
Flyvbjerg, Allan [4 ,5 ]
Bjerre, Mette [4 ,5 ]
Iversen, Allan Z. [3 ]
Galatius, Soren [3 ]
Frystyk, Jan [4 ,5 ]
Jensen, Jan S. [1 ,3 ,6 ]
机构
[1] Bispebjerg Hosp, Copenhagen, Denmark
[2] Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark
[3] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark
[4] Aarhus Univ Hosp, Med Res Lab, Inst Clin, Aarhus Fac Hlth Sci, DK-8000 Aarhus, Denmark
[5] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark
[6] Univ Copenhagen, Clin Inst Surg & Internal Med, Fac Hlth Sci, Copenhagen, Denmark
基金
英国医学研究理事会;
关键词
CARDIOVASCULAR-DISEASE; PLASMA OSTEOPROTEGERIN; CORONARY EVENTS; MARKERS; CALCIFICATION; INFLAMMATION; HEMOGLOBIN; PREDICTION; THERAPY; INSULIN;
D O I
10.1016/j.amjcard.2011.09.043
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Atherosclerosis is the main cause of cardiovascular disease, but the extent of atherosclerosis in individual patients is difficult to estimate. A biomarker of the atherosclerotic burden would be very valuable. The aim of the present study was to evaluate the association of plasma osteoprotegerin (OPG) to clinical and subclinical atherosclerotic disease in a large community-based, cross-sectional population study. In the Copenhagen City Heart Study, OPG concentrations were measured in 5,863 men and women. A total of 494 participants had been hospitalized for ischemic heart disease or ischemic stroke, and compared to controls, this group with clinical atherosclerosis had higher mean OPG (1,773 vs 1,337 ng/L, p < 0.001) and high-sensitivity C-reactive protein (2.3 vs 1.6 mg/L, p < 0.001). In a multivariate model with age, gender, body mass index, hypertension, diabetes, hypercholesterolemia, smoking status, estimated glomerular filtration rate, high-sensitivity C-reactive protein, and OPG, OPG remained significantly associated with clinical atherosclerosis (p < 0.01); high-sensitivity C-reactive protein, in contrast, did not (p = 0.74). In the control group without clinical atherosclerosis, OPG was independently associated with hypertension, diabetes, hypercholesterolemia, smoking, and subclinical peripheral atherosclerosis as measured by ankle brachial index. For each doubling of the plasma OPG concentration, the risk for subclinical peripheral atherosclerosis increased by 50% (p < 0.001) after multivariate adjustment. In conclusion, OPG appears to be a promising biomarker of atherosclerosis that is independently associated with traditional risk factors of atherosclerosis, subclinical peripheral atherosclerosis, and clinical atherosclerotic disease such as ischemic heart disease and ischemic stroke. (C) 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012; 109:515-520)
引用
收藏
页码:515 / 520
页数:6
相关论文
共 28 条
[1]
Relation of osteoprotegerin to coronary calcium and aortic plaque (from The Dallas Heart Study) [J].
Abedin, Moeen ;
Omland, Torbjorn ;
Ueland, Thor ;
Khera, Amit ;
Aukrust, Pal ;
Murphy, Sabina A. ;
Jain, Tulika ;
Gruntmanis, Ugis ;
McGuire, Darren K. ;
de Lemos, James A. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (04) :513-518
[2]
Association of serum osteoprotegerin with ankle-brachial index and urine albumin: Creatinine ratio in African-Americans and non-Hispanic whites [J].
Ali, Zeenat ;
Ellington, Allison A. ;
Mosley, Thomas H., Jr. ;
Kullo, Iftikhar J. .
ATHEROSCLEROSIS, 2009, 206 (02) :575-580
[3]
[Anonymous], 2011, 317 WHO
[4]
Appleyard M., 1989, Scand J Soc Med, V170, P1
[5]
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study [J].
Assmann, G ;
Cullen, P ;
Schulte, H .
CIRCULATION, 2002, 105 (03) :310-315
[6]
Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease [J].
Breland, Unni M. ;
Hollan, Ivana ;
Saatvedt, Kjell ;
Almdahl, Sven M. ;
Damas, Jan K. ;
Yndestad, Arne ;
Mikkelsen, Knut ;
Forre, Oystein T. ;
Aukrust, Pal ;
Ueland, Thor .
RHEUMATOLOGY, 2010, 49 (06) :1118-1127
[7]
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[8]
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].
Danesh, J ;
Wheeler, JG ;
Hirschfield, GM ;
Eda, S ;
Eiriksdottir, G ;
Rumley, A ;
Lowe, GDO ;
Pepys, MB ;
Gudnason, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397
[10]
Determinants of endothelial function in a cohort of patients with peripheral artery disease [J].
Golledge, J. ;
Leicht, A. S. ;
Crowther, R. G. ;
Glanville, S. ;
Clancy, P. ;
Sangla, K. S. ;
Spinks, W. L. ;
Quigley, F. .
CARDIOLOGY, 2008, 111 (01) :51-56